Additionally, the developed assay showed that alterations in the glycosylation pattern of CEA correlated well with CRC tumorigenesis and progression and that specific glycans were differently expressed on CEA in a stage-dependent manner. This evidence concerns the gene CEACAM5 and colorectal carcinoma.